Cleared Traditional

K870815 - KONTRON E.E.G. MONITOR, SUPERMON MODULE 7265 (FDA 510(k) Clearance)

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K870815 · Kontron Instruments, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1988
Decision
335d
Days
Class 2
Risk

K870815 is an FDA 510(k) clearance for the KONTRON E.E.G. MONITOR, SUPERMON MODULE 7265. Classified as Full-montage Standard Electroencephalograph (product code GWQ), Class II - Special Controls.

Submitted by Kontron Instruments, Inc. (Everett, US). The FDA issued a Cleared decision on February 1, 1988 after a review of 335 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Kontron Instruments, Inc. devices

Submission Details

510(k) Number K870815 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 03, 1987
Decision Date February 01, 1988
Days to Decision 335 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
187d slower than avg
Panel avg: 148d · This submission: 335d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GWQ Full-montage Standard Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWQ Full-montage Standard Electroencephalograph

All 187
Devices cleared under the same product code (GWQ) and FDA review panel - the closest regulatory comparables to K870815.
New Wave System
K260455 · Zeto, Inc. · Mar 2026
Flexset System
K233403 · Zeto, Inc. · Apr 2024
Neuronaute Plus
K231366 · Bioserenity Sas · Nov 2023
Q21
K221959 · Neurofield, Inc. · Aug 2023
SPARK Scan
K231457 · Spark Neuro, Inc. · Aug 2023
Cumulus Functional Neurophysiology Platform
K221963 · Cumulus Neuroscience Limited · Apr 2023